Search

Your search keyword '"Tangri, N."' showing total 509 results

Search Constraints

Start Over You searched for: Author "Tangri, N." Remove constraint Author: "Tangri, N."
509 results on '"Tangri, N."'

Search Results

2. An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States

4. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts

5. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

6. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

14. Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

15. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data

16. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

17. Adiposity and risk of decline in glomerular filtration rate : Meta-analysis of individual participant data in a global consortium

18. POS-322 INSIDE CKD: PROJECTING THE FUTURE BURDEN OF CHRONIC KIDNEY DISEASE IN THE AMERICAS AND THE ASIA-PACIFIC REGION USING MICROSIMULATION MODELLING

25. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

26. INTRODUCTION

27. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

29. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

30. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

31. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

32. Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar

34. Ein geringeres Risiko für CV-Ereignisse und Tod ist mit dem Therapiebeginn mit SGLT-2 vs. DPP-4 Inhibitoren assoziiert – Analyse der CVD-REAL-2-Studie

35. Systematic reviews: Getting started with designing effective search strategies and study screening forms

36. Age and Association of Kidney Measures With Mortality and End-stage Renal Disease

37. Clinico-radiological profile with suspicion of lung cancer and its correlation with flexible TBNA (transbronchial needle aspiration) and cytological analysis-initial results from a tertiary rural setup of Ambala District, Haryana

38. Past Decline Versus Current eGFR and Subsequent Mortality Risk

39. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

40. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

41. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

44. Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial

45. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

48. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

Catalog

Books, media, physical & digital resources